Stay updated on LBR-101 in High Frequency Episodic Migraine Clinical Trial

Sign up to get notified when there's something new on the LBR-101 in High Frequency Episodic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LBR-101 in High Frequency Episodic Migraine Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for LBR-101 (fremanezumab) is displayed, including its completed Phase 2 study design, eligibility criteria, outcomes, participating locations, and posted results and publications.
    Difference
    72%
    Check dated 2026-11-13T04:58:49.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.2 to v3.8.0 while the 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-30T05:42:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content, noting that both terms may appear during the transition.
    Difference
    1%
    Check dated 2026-10-23T03:20:56.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the study page remains an error page.
    Difference
    0.2%
    Check dated 2026-10-16T03:29:25.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-09T06:54:39.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study record content with a 403 message and a Home link. This blocks access to the trial details and related information, indicating a page-level access restriction.
    Difference
    17%
    Check dated 2026-09-25T07:48:42.000Z thumbnail image

Stay in the know with updates to LBR-101 in High Frequency Episodic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LBR-101 in High Frequency Episodic Migraine Clinical Trial page.